These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25328629)

  • 1. Characteristics of persons refusing oral polio vaccine during the immunization plus days - Sokoto, Nigeria 2011.
    Mohammed A; Sabitu K; Nguku P; Abanida E; Sheidu S; Dalhat M; Dankoli R; Gidado S; Suleiman I
    Pan Afr Med J; 2014; 18 Suppl 1(Suppl 1):10. PubMed ID: 25328629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the reasons for oral poliovirus vaccine refusals in northern Nigeria.
    Michael CA; Ogbuanu IU; Storms AD; Ohuabunwo CJ; Corkum M; Ashenafi S; Achari P; Biya O; Nguku P; Mahoney F;
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S125-30. PubMed ID: 25316826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges to health workers and their opinions about parents' refusal of oral polio vaccination in the Khyber Pakhtoon Khawa (KPK) province, Pakistan.
    Khan TM; Sahibzada MU
    Vaccine; 2016 Apr; 34(18):2074-81. PubMed ID: 26993330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refusal of oral polio vaccine in northwestern Pakistan: a qualitative and quantitative study.
    Murakami H; Kobayashi M; Hachiya M; Khan ZS; Hassan SQ; Sakurada S
    Vaccine; 2014 Mar; 32(12):1382-7. PubMed ID: 24492016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding vaccine hesitancy in polio eradication in northern Nigeria.
    Taylor S; Khan M; Muhammad A; Akpala O; van Strien M; Morry C; Feek W; Ogden E
    Vaccine; 2017 Nov; 35(47):6438-6443. PubMed ID: 29031691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demand-side determinants of timely vaccination of oral polio vaccine in social mobilization network areas of CORE Group polio project in Uttar Pradesh, India.
    Choudhary M; Solomon R; Awale J; Dey R
    BMC Infect Dis; 2018 May; 18(1):222. PubMed ID: 29769034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polio vaccine hesitancy in the networks and neighborhoods of Malegaon, India.
    Onnela JP; Landon BE; Kahn AL; Ahmed D; Verma H; O'Malley AJ; Bahl S; Sutter RW; Christakis NA
    Soc Sci Med; 2016 Mar; 153():99-106. PubMed ID: 26889952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of unmet needs to address noncompliant households during polio supplemental immunization activities in Kaduna state, 2014-2016.
    Iyal HA; Shuaib F; Dauda M; Suleiman A; Braka F; Tegegne SG; Nsubuga P; Nomhwange T; Yehualashet YG; Ishaku S; Warigon C; Zakari F; Umeh G; Samaila L; Abdullahi B; Hammanyero K; Dogo P; Adamu D; Vaz RG; Alemu W
    BMC Public Health; 2018 Dec; 18(Suppl 4):1309. PubMed ID: 30541500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
    Musa A; Mkanda P; Manneh F; Korir C; Warigon C; Gali E; Banda R; Umeh G; Nsubuga P; Chevez A; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S91-5. PubMed ID: 26609003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak.
    Russo G; Miglietta A; Pezzotti P; Biguioh RM; Bouting Mayaka G; Sobze MS; Stefanelli P; Vullo V; Rezza G
    BMC Public Health; 2015 Jul; 15():630. PubMed ID: 26156158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria.
    Michael CA; Ashenafi S; Ogbuanu IU; Ohuabunwo C; Sule A; Corkum M; Mackay S; Storms AD; Achari P; Biya O; Nguku P; Newberry D; Bwaka A; Mahoney F;
    J Infect Dis; 2014 Nov; 210 Suppl 1():S131-5. PubMed ID: 25316827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key issues in the persistence of poliomyelitis in Nigeria: a case-control study.
    Mangal TD; Aylward RB; Mwanza M; Gasasira A; Abanida E; Pate MA; Grassly NC
    Lancet Glob Health; 2014 Feb; 2(2):e90-7. PubMed ID: 25104665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-planning for immunization in Kaduna State, Nigeria: Lessons learnt, 2017.
    Umeh GC; Madubu DM; Korir C; Loveday N; Ishaku S; Iyal H; Omoleke SA; I Nomhwange T; Aliyu A; Musa A; Dankoli R; Mi Ningi A; Braka F; Dogo PM; Soba H; Iliyasu N
    Vaccine; 2018 Nov; 36(48):7361-7368. PubMed ID: 30366806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster survey evaluation of coverage and risk factors for failure to be immunized during the 1995 National Immunization Days in Egypt.
    Reichler MR; Darwish A; Stroh G; Stevenson J; Al Nasr MA; Oun SA; Wahdan MH
    Int J Epidemiol; 1998 Dec; 27(6):1083-9. PubMed ID: 10024208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polio elimination in Nigeria: A review.
    Nasir UN; Bandyopadhyay AS; Montagnani F; Akite JE; Mungu EB; Uche IV; Ismaila AM
    Hum Vaccin Immunother; 2016 Mar; 12(3):658-63. PubMed ID: 26383769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "This is a Pakhtun disease": Pakhtun health journalists' perceptions of the barriers and facilitators to polio vaccine acceptance among the high-risk Pakhtun community in Pakistan.
    Shah SFA; Ginossar T; Weiss D
    Vaccine; 2019 Jun; 37(28):3694-3703. PubMed ID: 31155417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitude and subjective wellbeing of non-compliant mothers to childhood oral polio vaccine supplemental immunization in Northern Nigeria.
    Umeh GC; Nomhwange TI; Shamang AF; Zakari F; Musa AI; Dogo PM; Gugong V; Iliyasu N
    BMC Public Health; 2018 Feb; 18(1):231. PubMed ID: 29422036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
    Altamirano J; Purington N; Behl R; Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Montero-Campos R; Cruz-Hervert LP; Boyle S; Modlin J; van Hoorebeke C; Leary S; Huang C; Sommer M; Ferreira-Guerrero E; Delgado-Sanchez G; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S4-S17. PubMed ID: 30376097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.